AdAlta Limited (ASX: 1AD) is an Australian public biotechnology company focused on the development and commercialisation of its i-body technology platform that has generated a pipeline of i-bodies (drugs), with an initial focus on treating fibrotic diseases.

Existing Shareholders

Help us manage our environmental impact (and investment)
Nominate now to receive all security holder communications electronically

  • Support your investment – reduce print/postal costs
  • Receive communications quickly and securely
  • Save paper and emissions – less printing/delivery

How?

Visit the Automic Registry Service. Log in or Register

  • Visit Settings (bottom left of screen)
  • Select Portfolio profile
  • Select Communications Method: Electronic Only;
  • Complete the contact name and email address fields, click Continue through to Review and Apply and start managing your portfolio online!

Stay up to date

Subscribe to AdAlta news alerts and updates, via our Stay in touch form.

Interested Investors

Stay up to date on AdAlta’s progress

Subscribe to AdAlta news alerts and updates, via our Stay in Touch form.

Learn More

Visit our Investor Page or the ASX website